In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per share.

Capcom delivered some huge news at the Game Awards last year - announcing a sequel to the legendary action-adventure game Okami was in development. It's being helmed by the original game's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Capcom has announced that a sequel to Ōkami is in development, with Hideki Kamiya returning as a director for the new project. The sequel will be co-developed by multiple studios that include staff ...

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report)’s share price traded down 4.6% during mid-day trading on Monday after an insider sold shares in the company.The stock traded as low as $52. ...

Analysts' ratings for Inari Medical NARI over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table encapsulates their recent ratings, offering a glimpse ...

If the link is not working, try using the right mouse button/save link target as... You can only log in once at a time on a download server. If you want to download a ...

As of December 3, 2024, the average one-year price target for Inari Medical is $66.15/share. The forecasts range from a low of $50.50 to a high of $90.30. The average price target represents an ...

Book these experiences for a close-up look at Inari.